Product Information
QC NASAL SPRAY 1% is a generic product labeled by Chain Drug Marketing Association, priced at $0.0703 per ML under NDC 83324021501. Its NADAC has been published 88 times since Jan 29, 2025.
Strength
1 g/100mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324021501
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
10/8/2024
Pharmacological Classes
Price Statistics
The NADAC for QC NASAL SPRAY 1% has been published 88 times since Jan 29, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0703 per ML |
|---|---|
| All-time high | $0.0703 (Sep 30, 2026) |
| All-time low | $0.0680 (Nov 19, 2025) |
| 52-week high | $0.0703 |
| 52-week low | $0.0680 |
| Median price | $0.0691 |
| Average price | $0.0691 |
| Largest weekly change | +1.1% (Sep 23, 2026) |
| Weeks tracked | 88 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Phenylephrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phenylephrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC NASAL SPRAY 1%?
The current National Average Drug Acquisition Cost (NADAC) for QC NASAL SPRAY 1%, manufactured by Chain Drug Marketing Association, is $0.0703 per ML (NDC 83324021501), effective Sep 30, 2026.
How has the price of QC NASAL SPRAY 1% changed over time?
Over the history we have for it, the NADAC for QC NASAL SPRAY 1% has held within roughly two percent of its current level. It has been tracked across 88 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for QC NASAL SPRAY 1%?
Since Jan 29, 2025, the NADAC for QC NASAL SPRAY 1% has ranged from a low of $0.0680 (Nov 19, 2025) to a high of $0.0703 (Sep 30, 2026), with a median of $0.0691 per ML.
Are there cheaper alternatives to QC NASAL SPRAY 1%?
No other NADAC-published product currently shares the active ingredient and strength of QC NASAL SPRAY 1% in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC NASAL SPRAY 1%?
QC NASAL SPRAY 1% (NDC 83324021501) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.